SARS-CoV-2 infection leads to greater risk of neurological complications than vaccines

Researchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.

Related Keywords

Nuffield ,Oxfordshire ,United Kingdom ,Edinburgh ,City Of ,Scotland ,Lahiru Handunnetthi ,Aziz Sheikh ,Martina Patone ,Emily Henderson ,Julia Hippisley Cox ,Professor Of Primary Care Research Development ,University Of Oxford ,Usher Institute ,Nuffield Department Of Primary Care Health Sciences ,University Of Edinburgh ,Nuffield Department Of Clinical Neurosciences ,Nature Medicine ,Medical Statistician ,Nuffield Department ,Primary Care Health Sciences ,Clinical Lecturer ,Clinical Neurosciences ,Clinical Epidemiology ,General Practice ,Primary Care Research ,Bell 39s Palsy ,Education ,Healthcare ,Medicine ,Primary Care ,Research ,Cars ,Ars Cov 2 ,Stroke ,Yndrome ,Vaccine ,